-
2024-512172-35-00
neurological disorders 4 2025-02-17
-
2024-517196-20-00
Paresthesia (numbness, tingling) secondary to chemother 10 2025-02-07
-
2024-519437-27-02
Glioblastoma 5 2025-02-03
-
2024-513475-41-00
Multiple Sclerosis 5 2025-02-03
-
2023-505320-54-00
Multiple System Atrophy 4 2025-01-30
-
2024-519933-53-00
Adult hydrocephalus 5 2025-01-29
-
2024-519936-18-00
CSF disorders 6 2025-01-29
-
2024-516510-38-00
Traumatic Brain Injury 4 2025-01-27
-
2024-520427-86-00
Autoimmune refractory epilepsy and Rasmussen Encephalit 1 2025-01-24
-
2024-519892-24-00
Chronic shoulder pain 5 2025-01-15
-
2024-514615-10-01
Subarachnoid hemorrhage 9 2025-01-14
-
2024-515062-13-00
acute ischemic stroke caused by occlusion of a large ve 5 2025-01-14
-
2024-520146-33-00
Cerebrospinal fluid circulation disorder seen in clinic 9 2025-01-13
-
2024-515901-24-00
Persistent post-traumatic headache 5 2025-01-10
-
2023-506942-22-01
paraneoplastic sensory neuropathy with anti-Hu antibodi 4 2025-01-10
-
2023-508718-40-00
Progressive supranuclear palsy 4 2025-01-09
-
2023-506998-35-00
Glioblastoma 5 2025-01-08
-
2023-504676-17-00
Patients with central neuropathic pain POST stroke 5 2025-01-06
-
2024-511968-81-00
Pelizaeus-Merzbacher disease 4 2024-12-27
-
2024-515970-28-00
Dystonic tremor syndrome 6 2024-12-20
-
2023-508813-18-00
Refractory Focal Onset Epilepsy 4 2024-12-18
-
2024-514303-34-00
Acute Incomplete Cervical Spinal Cord Injury 1 2024-12-18
-
2023-504686-23-00
anti-N-methyl-D-aspartate receptor encephalitis (anti-N 4 2024-12-10
-
2023-509900-14-00
Alzheimer’s Disease (AD) 3 2024-12-10